These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 1353858)
1. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]
2. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
3. [Salazosulfapyridine or 5-aminosalicylic acid]. van Hees PA Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762 [No Abstract] [Full Text] [Related]
4. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
5. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
6. Mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508 [No Abstract] [Full Text] [Related]
7. Will there be a next generation of sulfasalazine? Goldman P Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related]
8. 5-ASA for ulcerative colitis. Meyers S; Janowitz HD N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160 [No Abstract] [Full Text] [Related]
9. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention. Sandborn WJ Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478 [TBL] [Abstract][Full Text] [Related]
10. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease. Segars LW; Gales BJ Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685 [TBL] [Abstract][Full Text] [Related]
11. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
12. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid]. Malchow H Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152 [No Abstract] [Full Text] [Related]
15. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis. Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539 [No Abstract] [Full Text] [Related]
16. 5-aminosalicylic acid based drugs for the treatment of ulcerative colitis. Järnerot G Acta Gastroenterol Belg; 1987; 50(3):306-15. PubMed ID: 2894105 [No Abstract] [Full Text] [Related]
17. Sulphasalazine in inflammatory bowel disease: recent advances. Cooper BT N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428 [No Abstract] [Full Text] [Related]
18. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of ulcerative colitis]. Rückert Y Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661 [TBL] [Abstract][Full Text] [Related]